Spotlight on Cardiovascular Disease: Outcomes following TAVR, LDL receptor status and diabetes risk, statin intolerance, NOAC dosing, and more.
JAMA Editors' Summary · American Medical Association
March 10, 20156m 1s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Editor's Audio Summary by Eric D. Peterson, MD, MPH, Associate Editor, the Journal of the American Medical Association, for the March 10, 2015 issue